Skip to main content
. Author manuscript; available in PMC: 2010 Jun 15.
Published in final edited form as: J Neurosci Res. 2009 Sep;87(12):2728–2739. doi: 10.1002/jnr.22089

Fig. 9.

Fig. 9

Oligodendroglial pathology as a result of 3NP treatment. In order to examine the effects of 3NP treatment on oligodendrocytes, levels of APC, an oligodendrocytic marker, were examined in the corpus callosum of vehicle- and 3NP-treated NTg and vehicle- and 3NP-treated MBP-hasyn mice (A–D, respectively, and analyzed in E). APC levels were also examined in the cerebellar white matter of vehicle- and 3NP-treated NTg and vehicle- and 3NP-treated MBP-hasyn mice (F–I, respectively, and analyzed in J). Scale bar = 200 μM. *Significant difference (P < 0.05, one-way ANOVA and post hoc Fisher). [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]